Hence, detecting SPP1 gene or protein expression levels in local specimens such as lung tissue, BAL and sputum to predict coexisting LC in COPD is superior to plasma OPN and should be the direction of future research. The gene discussed is SPP1; the disease is laryngotracheoesophageal cleft.